Pancreatic Cancer Research

ResearcherInsermActive in the last 2 years

Jian‐Min Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2424-3969; OpenAlex author ID A5114378057. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
32
Papers, trials and grants by year

2013: 2 papers · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers

Papers 6

  1. Genetics and clinical implications of SPINK1 in the pancreatitis continuum and pancreatic cancer. Last author DOI 10.1186/s40246-025-00740-x↗
  2. Development and Validation of a Cell-Free DNA Fragmentomics-Based Model for Early Detection of Pancreatic Cancer. Co-author DOI 10.1200/jco.24.00287↗
  3. Prevalence of Germline Sequence Variations Among Patients With Pancreatic Cancer in China. Co-author DOI 10.1001/jamanetworkopen.2021.48721↗
  4. YY1 suppresses proliferation and migration of pancreatic ductal adenocarcinoma by regulating the CDKN3/MdM2/P53/P21 signaling pathway. Co-author DOI 10.1002/ijc.31173↗
  5. Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/ijc.27715↗
  6. miRNA-181b increases the sensitivity of pancreatic ductal adenocarcinoma cells to gemcitabine in vitro and in nude mice by targeting BCL-2. Co-author DOI 10.3892/or.2013.2297↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yi Miao · 5 shared papers, 2013–2025 · strength 0.43
  2. Zipeng Lu · 4 shared papers, 2013–2025 · strength 0.40
  3. Jishu Wei · 4 shared papers, 2013–2025 · strength 0.36
  4. Kuirong Jiang · 4 shared papers, 2013–2025 · strength 0.36
  5. Min Tu · 4 shared papers, 2013–2025 · strength 0.36
  6. Wen‐Bin Zou · 1 shared paper, 2025 · strength 0.30
  7. Qi-Wen Wang · 1 shared paper, 2025 · strength 0.30
  8. Zhuan Liao · 1 shared paper, 2025 · strength 0.30
  9. Lingdi Yin · 2 shared papers, 2022–2025 · strength 0.29
  10. Wentao Gao · 2 shared papers, 2022–2025 · strength 0.29
  11. Junli Wu · 2 shared papers, 2022–2025 · strength 0.29
  12. Zhihang Xu · 1 shared paper, 2025 · strength 0.17
  13. Ning Pu · 1 shared paper, 2025 · strength 0.17
  14. Yunpeng Peng · 1 shared paper, 2025 · strength 0.17
  15. Liang Liu · 1 shared paper, 2025 · strength 0.17
  16. Qiang Li · 1 shared paper, 2022 · strength 0.13
  17. Kai Zhang · 1 shared paper, 2022 · strength 0.13
  18. Chunhua Xi · 1 shared paper, 2022 · strength 0.13
  19. Hao Gao Gao · 1 shared paper, 2022 · strength 0.13
  20. Jun Yu · 1 shared paper, 2022 · strength 0.13
  21. Guodong Shi · 1 shared paper, 2018 · strength 0.07
  22. Yang Feng Wu · 1 shared paper, 2018 · strength 0.07
  23. Hao Yuan · 1 shared paper, 2018 · strength 0.07
  24. Dongfang Liu · 1 shared paper, 2018 · strength 0.07
  25. Pengfei Wu · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.